
Biologic Therapy Outcomes in Recalcitrant Atopic Dermatitis
A retrospective cohort study examining patient-reported outcomes and clinical remission rates following dupilumab initiation at an academic medical center.
Explore Dr. Lipton’s published research, recent speaking engagements, and clinical expertise in dermatology and dermato-oncology.

A retrospective cohort study examining patient-reported outcomes and clinical remission rates following dupilumab initiation at an academic medical center.

An analysis of screening protocols and risk stratification models for melanoma in patients with familial predisposition or prior malignancy.

A comprehensive review of cutaneous adverse effects arising from immune checkpoint inhibitors and evidence-based approaches to their management.
Practical guidance for clinicians managing patients with persistent acne unresponsive to standard regimens, including isotretinoin, spironolactone, and emerging biologics.
A deep dive into grading, recognition, and treatment algorithms for cutaneous immune-related adverse events, with illustrative case presentations.
Keynote address on integrating dermatology into oncology care pathways to proactively manage skin toxicities and improve quality of life for cancer patients.

Specialized management of psoriasis, lupus, pemphigus, and other complex skin conditions at the intersection of dermatology and immunology.

Comprehensive full-body skin exams, mole mapping, and dermoscopy for early detection and monitoring of atypical lesions and melanoma.

Dedicated dermatologic care for patients undergoing cancer treatment — managing skin toxicities, rashes, and nail changes caused by chemotherapy and immunotherapy.
Schedule a personalized consultation with Dr. Lipton and take the first step toward healthier, confident skin with expert-guided care.